Atlas Trials

A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Clinical trial NCT05615363 · COMPLETED

Trial details

NCT number
NCT05615363
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cardiac Edema (CHF)
Start date
2023-01-10
Primary completion
2024-10-21
Enrollment
157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.